Fortress Biotech, Inc. — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3ffea48c-1eb8-40ea-a654-5364b9c4218c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $61.2M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-037874 |
| FY 2024 | $55.1M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-004160 |
| FY 2023 | $59.7M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-004272 |
| FY 2022 | $71.0M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-005282 |
| FY 2021 | $63.1M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-004487 |
| FY 2020 | $44.5M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-003815 |
| FY 2019 | $34.9M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-034133 |
| FY 2018 | $23.4M | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-014617 |
| FY 2017 | $15.5M | 2017-01-01 – 2017-12-31 | evidence 0001144204-19-014617 |
| FY 2016 | $16.5M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-015137 |
| FY 2015 | $863.0k | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-088262 |
| FY 2014 | $0 | 2014-01-01 – 2014-12-31 | evidence 0001144204-16-088262 |
| FY 2013 | $0 | 2013-01-01 – 2013-12-31 | evidence 0001144204-16-088262 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Fortress Biotech, Inc. — all facts · Net Income · Operating Income